Stay updated on Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No visible changes to the study details on the page.
    Difference
    0.0%
    Check dated 2026-04-16T11:11:52.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added the NEJM 2015 paper by Larkin et al. on Combined Nivolumab and Ipilimumab for untreated melanoma; removed the Erratum entry for that publication.
    Difference
    0.0%
    Check dated 2026-04-02T04:56:33.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T19:34:16.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T17:56:12.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Publications section updated: two new articles added and one article removed.
    Difference
    0.1%
    Check dated 2026-03-04T15:09:05.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the lapse-in-government-funding notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T10:01:33.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.